SLU-PP-332
Also known as ERR agonist, Exercise-mimetic small molecule
A small-molecule estrogen-related receptor agonist studied preclinically for exercise-mimetic effects, mitochondrial metabolism, endurance signaling, and energy expenditure.
Overview
SLU-PP-332 is not a peptide. It is a small-molecule research compound designed to activate estrogen-related receptors, a nuclear receptor family involved in oxidative metabolism.
The Science
The interest comes from exercise-mimetic signaling: can a compound activate transcriptional programs associated with endurance and mitochondrial metabolism?
- ERR signaling - nuclear receptor control of energy metabolism genes.
- Mitochondrial biology - oxidative metabolism and endurance-related pathways.
- Preclinical performance models - animal data drive most public interest.
Evidence Snapshot
SLU-PP-332 is early-stage and preclinical. It should be treated as a metabolism research tool, not as an established human endurance or weight-loss drug.
Related
More in Metabolic
Adipotide
Research compoundMetabolic
An experimental peptidomimetic studied preclinically for targeting adipose vasculature through prohibitin-related mechanisms, with major translational and safety uncertainty.
AICAR
Research compoundMetabolic
Not a peptideNucleotide analog
A nucleotide analog and AMPK-pathway research tool studied in cellular energy sensing, exercise-mimetic biology, cardiometabolic research, and anti-doping contexts.
AOD-9604
Research compoundMetabolic
A synthetic fragment of growth hormone designed to isolate GH's fat-mobilizing effects without its growth-promoting or blood-sugar-altering activity — a tool researchers and self-experimenters study for body composition and joint health.